Henry Schein (NASDAQ:HSIC) Coverage Initiated by Analysts at Wells Fargo & Company

Wells Fargo & Company initiated coverage on shares of Henry Schein (NASDAQ:HSIC) in a research note published on Friday morning, MarketBeat reports. The brokerage issued an equal weight rating and a $80.00 price target on the stock.

HSIC has been the topic of a number of other reports. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. Barrington Research upped their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Thursday, January 30th. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Jefferies Financial Group boosted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Eight research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and a consensus price target of $80.09.

Henry Schein Trading Down 2.1 %

NASDAQ:HSIC opened at $76.00 on Friday. The firm’s fifty day moving average is $74.01 and its 200-day moving average is $72.00. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.63. The firm has a market cap of $9.48 billion, a P/E ratio of 31.28, a P/E/G ratio of 2.21 and a beta of 0.91.

Insiders Place Their Bets

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

Institutional investors have recently made changes to their positions in the company. Clarkston Capital Partners LLC grew its stake in shares of Henry Schein by 5.4% in the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after acquiring an additional 71,560 shares in the last quarter. Nuance Investments LLC grew its stake in shares of Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after acquiring an additional 414,748 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of Henry Schein in the 3rd quarter worth $515,000. Olstein Capital Management L.P. grew its stake in shares of Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after acquiring an additional 16,000 shares in the last quarter. Finally, Thrivent Financial for Lutherans grew its stake in shares of Henry Schein by 1,848.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 105,415 shares of the company’s stock worth $7,685,000 after acquiring an additional 100,006 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.